Underlying Reasons for Smoking–Reply–I
| Autor: | Michael V. Burke, J. Taylor Hays, Jon O. Ebbert, David D. McFadden, Ivana T. Croghan, Darrell R. Schroeder, Richard D. Hurt |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
medicine.medical_specialty
business.industry Methylphenidate General Medicine medicine.disease Mental health Mood medicine Attention deficit hyperactivity disorder Anxiety medicine.symptom Medical diagnosis business Psychiatry Letter to the Editor Anxiety disorder Depression (differential diagnoses) Clinical psychology medicine.drug |
| Zdroj: | Mayo Clinic Proceedings. 86:469 |
| ISSN: | 0025-6196 |
| Popis: | We thank Dr Cobb for his comments regarding our article. He is correct that smokers have many comorbid psychiatric conditions,1 particularly anxiety, depression, and other substance use disorders. Approximately 40% of patients in our residential program have 1 or more of these diagnoses. We do not target treatment at these conditions, but we do desire comorbid mental health problems to be under good control before we admit patients to our program. It is unclear how much tobacco dependence arises from self-medication of psychiatric symptoms vs a common predisposition to both tobacco dependence and a mood or anxiety disorder. Similarly, comorbid medical conditions are determined to be stable through a telephone screening process before we admit a patient to our program. Treating tobacco dependence effectively in any setting is difficult, if not impossible, if a comorbid psychiatric or medical condition is poorly controlled. Few published data are available on how best to treat comorbid tobacco dependence and adult attention deficit hyperactivity disorder. We were involved in one small trial using methylphenidate for treatment of tobacco dependence in patients with established adult attention deficit hyperactivity disorder, and the results (yet unpublished) were disappointing. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|